APA (7th ed.) Citation

JT, J., A, E., CL, W., CA, S., DF, A., S, T., . . . DL, B. (2024). Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial. Contraception, 137, 110475. https://doi.org/10.1016/j.contraception.2024.110475

Chicago Style (17th ed.) Citation

JT, Jensen, Edelman A, Westhoff CL, Schreiber CA, Archer DF, Teal S, Thomas M, Brown J, and Blithe DL. "Use of Serum Evaluation of Contraceptive and Ovarian Hormones to Assess Reduced Risk of Pregnancy Among Women Presenting for Emergency Contraception in a Multicenter Clinical Trial." Contraception 137 (2024): 110475. https://doi.org/10.1016/j.contraception.2024.110475.

MLA (9th ed.) Citation

JT, Jensen, et al. "Use of Serum Evaluation of Contraceptive and Ovarian Hormones to Assess Reduced Risk of Pregnancy Among Women Presenting for Emergency Contraception in a Multicenter Clinical Trial." Contraception, vol. 137, 2024, p. 110475, https://doi.org/10.1016/j.contraception.2024.110475.